Brief: CytRx announces presentation of interim phase 2 data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma
29/06/2015 14:00
June 29 (Reuters) - CytRx Corp CYTR.O : * CytRx announces presentation of interim phase 2 data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma * Source text for Eikon ID:nPn9VjdC * Further company coverage CYTR.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C